Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franz Zehentmayr

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
MMW Fortschritte Der Medizin|July 9, 2016
[Not Available]Franz Zehentmayr
Journal of Thoracic Disease|February 20, 2025
Immediate start of durvalumab after chemoradiotherapy in unresectable non-small cell lung cancer UICC stage III: early results from the TORG1937/DATE studyBrane Grambozov, Markus Stana, Franz Zehentmayr
Translational Lung Cancer Research|February 9, 2026
Lung cancer survivorship: natural language processing for automated abstraction of follow-up computed tomography indicationBrane Grambozov, Elvis Ruznic, Franz Zehentmayr
Breast (Edinburgh, Scotland)|October 1, 2013
Partial breast re-irradiation for local recurrence of breast carcinoma: Benefit and long term side effectsFelix Sedlmayer, Franz Zehentmayr, Gerd Fastner
Chinese Clinical Oncology|June 11, 2026
Toxicity management in thoracic chemoradioimmunotherapy: pirfenidone for low grade pneumonitis and lung fibrosisFranz Zehentmayr, Elvis Ruznic, Raphaela Moosbrugger, et al.
Translational Cancer Research|June 17, 2026
Computed tomography monitoring of small lung nodules: finding the right balanceBrane Grambozov, Josef Karner, Elvis Ruznic, et al.
Chinese Clinical Oncology|July 9, 2026
Toxicity management in thoracic chemoradioimmunotherapy: pirfenidone for low grade pneumonitis and lung fibrosisFranz Zehentmayr, Elvis Ruznic, Raphaela Moosbrugger, et al.
Thoracic Cancer|April 24, 2020
Radiation dose escalation with modified fractionation schedules for locally advanced NSCLC: A systematic reviewFranz Zehentmayr, Brane Grambozov, Julia Kaiser, et al.
MMW Fortschritte Der Medizin|September 16, 2011
[Neoadjuvant radiochemotherapy for rectal cancer]Franz Zehentmayr, Maria Wolf, Yeshey Weissenborn, et al.
Radiation Oncology (London, England)|April 17, 2012
Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centreMaria C Wolf, Franz Zehentmayr, Michael Schmidt, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
MMW Fortschritte Der Medizin|July 9, 2016
[Not Available]Franz Zehentmayr
Journal of Thoracic Disease|February 20, 2025
Immediate start of durvalumab after chemoradiotherapy in unresectable non-small cell lung cancer UICC stage III: early results from the TORG1937/DATE studyBrane Grambozov, Markus Stana, Franz Zehentmayr
Translational Lung Cancer Research|February 9, 2026
Lung cancer survivorship: natural language processing for automated abstraction of follow-up computed tomography indicationBrane Grambozov, Elvis Ruznic, Franz Zehentmayr
Breast (Edinburgh, Scotland)|October 1, 2013
Partial breast re-irradiation for local recurrence of breast carcinoma: Benefit and long term side effectsFelix Sedlmayer, Franz Zehentmayr, Gerd Fastner
Chinese Clinical Oncology|June 11, 2026
Toxicity management in thoracic chemoradioimmunotherapy: pirfenidone for low grade pneumonitis and lung fibrosisFranz Zehentmayr, Elvis Ruznic, Raphaela Moosbrugger, et al.
Translational Cancer Research|June 17, 2026
Computed tomography monitoring of small lung nodules: finding the right balanceBrane Grambozov, Josef Karner, Elvis Ruznic, et al.
Chinese Clinical Oncology|July 9, 2026
Toxicity management in thoracic chemoradioimmunotherapy: pirfenidone for low grade pneumonitis and lung fibrosisFranz Zehentmayr, Elvis Ruznic, Raphaela Moosbrugger, et al.
Thoracic Cancer|April 24, 2020
Radiation dose escalation with modified fractionation schedules for locally advanced NSCLC: A systematic reviewFranz Zehentmayr, Brane Grambozov, Julia Kaiser, et al.
MMW Fortschritte Der Medizin|September 16, 2011
[Neoadjuvant radiochemotherapy for rectal cancer]Franz Zehentmayr, Maria Wolf, Yeshey Weissenborn, et al.
Radiation Oncology (London, England)|April 17, 2012
Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centreMaria C Wolf, Franz Zehentmayr, Michael Schmidt, et al.
Pageof 6